1991
DOI: 10.1097/00000441-199109000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Human Type IV Collagenase by a Highly Conserved Peptide Sequence Derived from Its Prosegment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

1993
1993
2006
2006

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(12 citation statements)
references
References 41 publications
1
11
0
Order By: Relevance
“…Removal of Va177 by C-terminal truncation let to complete loss of inhibitory activity, as did substitution of Cys 75. The conserved sequence, MRKPRCGNPDV, has been shown to inhibit active human Type IV collagenase [4]. Our data confirm and extend this observation and those of Park et al [8], who showed that PRCGVPDV was a weak inhibitor of transin, the rat equivalent of human stromelysin, The data are consistent with the hypothesis that these peptides inhibit stromelysin via coordination of Cys 75 with the active-site zinc.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Removal of Va177 by C-terminal truncation let to complete loss of inhibitory activity, as did substitution of Cys 75. The conserved sequence, MRKPRCGNPDV, has been shown to inhibit active human Type IV collagenase [4]. Our data confirm and extend this observation and those of Park et al [8], who showed that PRCGVPDV was a weak inhibitor of transin, the rat equivalent of human stromelysin, The data are consistent with the hypothesis that these peptides inhibit stromelysin via coordination of Cys 75 with the active-site zinc.…”
Section: Discussionsupporting
confidence: 92%
“…76/1001, 340 Kingsland Street, Nutley, NJ 07110, USA Cys 75 is thought to coordinate with the active-site zinc [3] and to maintain the proenzyme in an inactive form. Since peptide sequences from the propeptide domain inhibit MMPs [4], the goal of this study was to define the minimal sequence in [Met69-GlyS~ able to inhibit stromelysin.…”
Section: Introductionmentioning
confidence: 99%
“…In vitro studies of the activation mechanism of this enzyme has yielded new insights into the molecular basis of proenzyme latency (Stetler-Stevenson et al, 1991). In this study, AAC-11 transfected cancer cells expressed an elevated level of MMP-2 protein as assessed by immunoblotting.…”
Section: Kim Et Almentioning
confidence: 96%
“…The amino terminal portion of the zymogen contains a highly conserved sequence with a free cysteine residue adjacent to the activation locus which is lost following conversion of the latent proenzyme forms. Synthetic peptides containing the conserved consequence KPRCGV(X)PD, corresponding to the prosegment portion of MMPs, are capable of inhibiting activated MMP-2 [26]. We reported a similar prosegment peptide corresponding to rat MMP-3 (transin), LMHKPRCGVPDVGG (splMP), inhibits both MMP-2 and MMP-3 from several species [17].…”
Section: Invasive Potentialmentioning
confidence: 99%